Share

Medica Sur, S.A.B. de C.V. Stocks

MX$ 56.1Last Updated 11.11.2025

Issuer Rating

4/7

Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

MX$ 289.14M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
MX$ 56.1
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services....

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, un

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of MEDICAB.MX is 77 and suggests 37% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks